Print

Optimer Pharmaceuticals, Inc. (OPTR) Reports First Quarter 2013 Financial Results  
5/10/2013 6:28:37 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERSEY CITY, N.J., May 9, 2013 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013.

Financial Highlights

•First quarter 2013 DIFICID net product sales in the U.S. and Canada of $16.8 million, compared to $14.4 million in 2012

Help employers find you! Check out all the jobs and post your resume.

//-->